EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
Introduction Growth hormone (GH) is a pituitary hormone with pleiotropic effects. After being secreted into the general circulation, GH binds to its receptor with subsequent direct effects and insulin-like growth factor (IGF)-mediated effects
Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Andre Madsen in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
adoption of continuous hormone references using the well-established ‘LMS’ growth curve algorithm provides a clinically useful framework to standardize age- and sex-dependent variance and obtain standard deviation scores (SDS) ( 4 , 7 , 8 , 9 ). Briefly
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Hans Valdemar López Krabbe in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jørgen Holm Petersen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Fertility, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Louise Laub Asserhøj in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Peter Christiansen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Rikke Beck Jensen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Line Hartvig Cleemann in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Casper P Hagen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lærke Priskorn in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Katharina M Main in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark, had non-mosaic 47,XXY KS and had undergone whole-body DXA and/or had minimum one serum concentration of testosterone determined by liquid chromatography-tandem mass spectrometry (LC
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Search for other papers by Alberto Ferlin in
Google Scholar
PubMed
Search for other papers by Joerg Gromoll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Armin Raznahan in
Google Scholar
PubMed
Search for other papers by Sophie van Rijn in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed
Search for other papers by Nicole Tartaglia in
Google Scholar
PubMed
Search for other papers by Hanna Swaab in
Google Scholar
PubMed
thinking seems to be moving away from searching for single candidate genes, like the first gene, the SHOX gene, that was shown to be involved in growth many years ago ( 3 , 4 ), and since extensively studied ( 5 ). Currently, the picture emerging focuses
Search for other papers by Silvia Ciancia in
Google Scholar
PubMed
Search for other papers by Vanessa Dubois in
Google Scholar
PubMed
Search for other papers by Martine Cools in
Google Scholar
PubMed
skeletal growth is heavily influenced by the genetic background, several other factors influence the bone structure and quality (e.g. chronic systemic illnesses, muscular disorders, metabolic disorders, and some medications). Also, a healthy lifestyle, with
Search for other papers by Michael C Velarde in
Google Scholar
PubMed
Search for other papers by Mikaela Erlinda M Bucu in
Google Scholar
PubMed
Search for other papers by Maria Antonia E Habana in
Google Scholar
PubMed
are some of the most used medications for suppressing the growth of endometriotic tissues ( 23 ). Intake of oral progestins, such as dienogest, inhibits estrogen-induced mitosis and shrinks endometriotic lesions, while continuous administration of GnRH
Search for other papers by R H M Dykgraaf in
Google Scholar
PubMed
Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by S Schalekamp-Timmermans in
Google Scholar
PubMed
Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by M C Adank in
Google Scholar
PubMed
Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by S A A van den Berg in
Google Scholar
PubMed
Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by B M N van de Lang-Born in
Google Scholar
PubMed
Search for other papers by T I M Korevaar in
Google Scholar
PubMed
Search for other papers by A Kumar in
Google Scholar
PubMed
Search for other papers by B Kalra in
Google Scholar
PubMed
Search for other papers by G V Savjani in
Google Scholar
PubMed
Division of Obstetrics and Fetal Medicine, Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Search for other papers by E A P Steegers in
Google Scholar
PubMed
Search for other papers by Y V Louwers in
Google Scholar
PubMed
Search for other papers by J S E Laven in
Google Scholar
PubMed
Introduction Anti‐Müllerian hormone (AMH) is a glycoprotein from the transforming growth factor‐beta family and is produced by granulosa cells of antral and preantral follicles ( 1 , 2 ). AMH plays an important role in ovarian function and
Search for other papers by Tristan Avril in
Google Scholar
PubMed
Search for other papers by Quentin Hennocq in
Google Scholar
PubMed
Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Search for other papers by Juliane Leger in
Google Scholar
PubMed
Search for other papers by Dominique Simon in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
↑ Testicular volume ↑ Testosterone ↑ Penile length ↑ Inhibin B ↑ AMH n , number of patients. In our study, penile growth was more efficient in the injection group related to a greater increase in testosterone levels under
Division of Biomedical Information Analysis, Iwate Tohoku Medical Megabank Organization, Disaster Reconstruction Center, Iwate Medical University, Yahaba, Japan
Search for other papers by Shiori Minabe in
Google Scholar
PubMed
Search for other papers by Kinuyo Iwata in
Google Scholar
PubMed
Search for other papers by Youki Watanabe in
Google Scholar
PubMed
Search for other papers by Hirotaka Ishii in
Google Scholar
PubMed
Faculty of Health Science, Bukkyo University, Kyoto, Japan
Search for other papers by Hitoshi Ozawa in
Google Scholar
PubMed
nutritional environment. Additionally, prenatal undernutrition stimulates obesogenic effects, such as rapid catch-up growth at 4 weeks following LBW, visceral fat accumulation, and increased calorie intake and plasma triglyceride levels in adulthood. These
Search for other papers by Yanfei Chen in
Google Scholar
PubMed
Search for other papers by Mei Li in
Google Scholar
PubMed
Search for other papers by Binrong Liao in
Google Scholar
PubMed
Search for other papers by Jingzi Zhong in
Google Scholar
PubMed
Search for other papers by Dan Lan in
Google Scholar
PubMed
, insulin-like growth factor-1 (IGF-1), insulin) have shown potential roles in the diagnosis of CPP ( 10 , 11 , 12 ). Recently, Kutlu et al. ( 13 ) reported the role of another novel adipomyokine, irisin, in the diagnosis of CPP, and their study implied